| MEPS HC-220A CODEBOOK |
| 2020 PRESCRIBED MEDICINES |
| DATE: June 1, 2022 |
| Variable Name: |
TC1S1_1 |
| Description: |
MULTUM THERAPEUT SUB-SUB-CLASS FOR TC1S1 |
| Format: |
3.0 |
| Type: |
NUM |
| Start: |
443 |
| End: |
445 |
|
|
|
| -15 CANNOT BE COMPUTED |
3,095 |
34,972,265 |
| -1 INAPPLICABLE |
97,726 |
1,052,281,250 |
| 38 VIRAL VACCINES |
94 |
1,157,595 |
| 59 MISCELLANEOUS ANALGESICS |
548 |
5,610,164 |
| 60 NARCOTIC ANALGESICS |
4,072 |
44,591,721 |
| 61 NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
5,390 |
54,295,094 |
| 62 SALICYLATES |
1,948 |
17,287,373 |
| 63 ANALGESIC COMBINATIONS |
225 |
2,542,717 |
| 69 BENZODIAZEPINES |
1,885 |
18,924,367 |
| 70 MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND H |
3,807 |
41,698,692 |
| 76 MISCELLANEOUS ANTIDEPRESSANTS |
141 |
1,826,352 |
| 77 MISCELLANEOUS ANTIPSYCHOTIC AGENTS |
107 |
1,051,630 |
| 89 ANTICHOLINERGICS/ANTISPASMODICS |
438 |
4,924,632 |
| 102 CONTRACEPTIVES |
3,101 |
48,848,596 |
| 137 TOPICAL ANTI-INFECTIVES |
70 |
759,567 |
| 138 TOPICAL STEROIDS |
1,460 |
18,264,249 |
| 139 TOPICAL ANESTHETICS |
133 |
1,186,240 |
| 140 MISCELLANEOUS TOPICAL AGENTS |
50 |
554,258 |
| 141 TOPICAL STEROIDS WITH ANTI-INFECTIVES |
84 |
1,007,453 |
| 143 TOPICAL ACNE AGENTS |
484 |
6,467,727 |
| 144 TOPICAL ANTIPSORIATICS |
44 |
518,466 |
| 154 LOOP DIURETICS |
3,206 |
30,427,201 |
| 155 POTASSIUM-SPARING DIURETICS |
1,192 |
13,354,566 |
| 156 THIAZIDE DIURETICS |
4,646 |
47,658,269 |
| 157 CARBONIC ANHYDRASE INHIBITORS |
58 |
934,527 |
| 159 FIRST GENERATION CEPHALOSPORINS |
621 |
7,232,196 |
| 160 SECOND GENERATION CEPHALOSPORINS |
66 |
841,774 |
| 161 THIRD GENERATION CEPHALOSPORINS |
187 |
2,400,304 |
| 163 OPHTHALMIC ANTI-INFECTIVES |
442 |
5,157,189 |
| 164 OPHTHALMIC GLAUCOMA AGENTS |
2,562 |
28,166,830 |
| 165 OPHTHALMIC STEROIDS |
342 |
3,777,180 |
| 166 OPHTHALMIC STEROIDS WITH ANTI-INFECTIVES |
219 |
2,471,726 |
| 167 OPHTHALMIC ANTI-INFLAMMATORY AGENTS |
449 |
4,821,582 |
| 168 OPHTHALMIC LUBRICANTS AND IRRIGATIONS |
251 |
2,393,191 |
| 170 OTIC ANTI-INFECTIVES |
61 |
752,884 |
| 171 OTIC STEROIDS WITH ANTI-INFECTIVES |
119 |
1,674,010 |
| 173 HMG-COA REDUCTASE INHIBITORS |
19,464 |
206,207,292 |
| 174 MISCELLANEOUS ANTIHYPERLIPIDEMIC AGENTS |
85 |
1,238,695 |
| 178 SKELETAL MUSCLE RELAXANTS |
3,621 |
38,228,675 |
| 180 ADRENERGIC BRONCHODILATORS |
6,307 |
62,695,343 |
| 181 BRONCHODILATOR COMBINATIONS |
3,939 |
39,600,678 |
| 182 ANDROGENS AND ANABOLIC STEROIDS |
306 |
3,359,583 |
| 183 ESTROGENS |
1,087 |
13,299,528 |
| 185 PROGESTINS |
260 |
3,617,744 |
| 191 NARCOTIC ANALGESIC COMBINATIONS |
4,549 |
45,818,018 |
| 193 ANTIMIGRAINE AGENTS |
902 |
12,537,015 |
| 195 5HT3 RECEPTOR ANTAGONISTS |
769 |
8,773,585 |
| 196 PHENOTHIAZINE ANTIEMETICS |
319 |
3,310,938 |
| 197 ANTICHOLINERGIC ANTIEMETICS |
651 |
7,115,903 |
| 198 MISCELLANEOUS ANTIEMETICS |
99 |
642,109 |
| 201 BARBITURATE ANTICONVULSANTS |
169 |
1,655,568 |
| 203 BENZODIAZEPINE ANTICONVULSANTS |
2,581 |
30,583,241 |
| 205 ANTICHOLINERGIC ANTIPARKINSON AGENTS |
232 |
2,060,460 |
| 208 SSRI ANTIDEPRESSANTS |
10,182 |
119,807,356 |
| 209 TRICYCLIC ANTIDEPRESSANTS |
1,176 |
14,114,851 |
| 211 PLATELET AGGREGATION INHIBITORS |
2,045 |
21,756,766 |
| 213 SULFONYLUREAS |
2,544 |
24,658,908 |
| 214 BIGUANIDES |
9,008 |
92,591,486 |
| 215 INSULIN |
5,855 |
54,600,424 |
| 217 BISPHOSPHONATES |
910 |
9,444,920 |
| 224 AMINOPENICILLINS |
1,269 |
16,074,218 |
| 225 BETA-LACTAMASE INHIBITORS |
506 |
6,086,124 |
| 226 NATURAL PENICILLINS |
90 |
905,445 |
| 229 PURINE NUCLEOSIDES |
703 |
8,984,537 |
| 235 POLYENES |
57 |
582,108 |
| 236 AZOLE ANTIFUNGALS |
313 |
3,461,889 |
| 237 MISCELLANEOUS ANTIFUNGALS |
120 |
1,286,843 |
| 238 ANTIMALARIAL QUINOLINES |
462 |
4,992,835 |
| 239 MISCELLANEOUS ANTIMALARIALS |
720 |
9,152,605 |
| 241 FIBRIC ACID DERIVATIVES |
972 |
10,348,811 |
| 244 NASAL LUBRICANTS AND IRRIGATIONS |
24 |
218,430 |
| 245 NASAL STEROIDS |
1,947 |
19,527,369 |
| 246 NASAL ANTIHISTAMINES AND DECONGESTANTS |
365 |
4,290,709 |
| 248 TOPICAL EMOLLIENTS |
102 |
807,542 |
| 261 HEPARINS |
61 |
580,073 |
| 262 COUMARINS AND INDANDIONES |
1,126 |
11,467,999 |
| 267 OPHTHALMIC ANTIHISTAMINES AND DECONGESTAN |
285 |
3,114,108 |
| 271 THIAZOLIDINEDIONES |
383 |
3,443,215 |
| 274 CARDIOSELECTIVE BETA BLOCKERS |
7,978 |
82,630,699 |
| 275 NON-CARDIOSELECTIVE BETA BLOCKERS |
2,602 |
26,199,595 |
| 276 DOPAMINERGIC ANTIPARKINSONISM AGENTS |
800 |
7,992,826 |
| 278 COX-2 INHIBITORS |
655 |
7,089,212 |
| 281 NEURAMINIDASE INHIBITORS |
239 |
3,185,814 |
| 283 THROMBIN INHIBITORS |
105 |
1,033,241 |
| 285 FACTOR XA INHIBITORS |
2,252 |
22,563,488 |
| 290 TOPICAL ANTIBIOTICS |
281 |
3,459,879 |
| 292 TOPICAL ANTIFUNGALS |
697 |
7,299,232 |
| 296 INHALED CORTICOSTEROIDS |
1,010 |
10,833,347 |
| 299 ANTICHOLINERGIC BRONCHODILATORS |
785 |
7,696,156 |
| 301 GLUCOCORTICOIDS |
2,606 |
28,739,250 |
| 304 MACROLIDES |
896 |
11,137,370 |
| 306 PHENYLPIPERAZINE ANTIDEPRESSANTS |
2,595 |
26,210,732 |
| 307 TETRACYCLIC ANTIDEPRESSANTS |
585 |
6,601,132 |
| 308 SSNRI ANTIDEPRESSANTS |
3,573 |
40,836,919 |
| 311 DIBENZAZEPINE ANTICONVULSANTS |
671 |
7,135,580 |
| 314 ANTIDIABETIC COMBINATIONS |
812 |
9,384,416 |
| 316 CHOLESTEROL ABSORPTION INHIBITORS |
655 |
7,029,303 |
| 327 ANTIVIRAL COMBINATIONS |
370 |
3,934,759 |
| 341 ATYPICAL ANTIPSYCHOTICS |
2,793 |
29,712,771 |
| 345 FATTY ACID DERIVATIVE ANTICONVULSANTS |
488 |
6,000,123 |
| 347 GAMMA-AMINOBUTYRIC ACID ANALOGS |
5,912 |
59,188,934 |
| 348 TRIAZINE ANTICONVULSANTS |
887 |
10,801,629 |
| 350 PYRROLIDINE ANTICONVULSANTS |
666 |
7,967,536 |
| 351 CARBONIC ANHYDRASE INHIBITOR ANTICONVULSA |
1,138 |
12,798,986 |
| 371 DIPEPTIDYL PEPTIDASE 4 INHIBITORS |
1,144 |
12,194,813 |
| 373 INCRETIN MIMETICS |
1,568 |
16,547,988 |
| 380 TOPICAL DEBRIDING AGENTS |
6 |
93,358 |
| 381 TOPICAL DEPIGMENTING AGENTS |
59 |
585,092 |
| 385 GROUP I ANTIARRHYTHMICS |
431 |
4,333,516 |
| 386 GROUP II ANTIARRHYTHMICS |
686 |
8,941,105 |
| 387 GROUP III ANTIARRHYTHMICS |
449 |
4,436,010 |
| 388 GROUP IV ANTIARRHYTHMICS |
1,310 |
13,723,467 |
| 389 GROUP V ANTIARRHYTHMICS |
212 |
1,905,634 |
| 394 TOPICAL ASTRINGENTS |
2 |
21,624 |
| 395 TOPICAL KERATOLYTICS |
3 |
47,955 |
| 444 SELECTIVE IMMUNOSUPPRESSANTS |
90 |
956,922 |
| 448 TOPICAL NON-STEROIDAL ANTI-INFLAMMATORIES |
494 |
4,603,508 |
| 450 TOPICAL ANTINEOPLASTICS |
85 |
962,262 |
| 453 TOPICAL RUBEFACIENT |
22 |
161,483 |
| 455 GUANYLATE CYCLASE-C AGONISTS |
162 |
1,796,464 |
| 458 SGLT-2 INHIBITORS |
1,057 |
10,932,094 |
| 461 TOPICAL ANTI-ROSACEA AGENTS |
3 |
37,532 |
| 467 ACE INHIBITORS WITH THIAZIDES |
1,422 |
14,249,996 |
| 470 MISCELLANEOUS ANTIHYPERTENSIVE COMBINATIO |
14 |
161,443 |
| 472 BETA BLOCKERS WITH THIAZIDES |
213 |
2,403,910 |
| 473 ANGIOTENSIN II INHIBITORS WITH THIAZIDES |
1,215 |
12,457,170 |
| 475 POTASSIUM SPARING DIURETICS WITH THIAZIDE |
481 |
5,024,503 |
| 476 ACE INHIBITORS WITH CALCIUM CHANNEL BLOCK |
309 |
3,434,364 |
| 484 PCSK9 INHIBITORS |
112 |
979,183 |
| 502 CGRP INHIBITORS |
267 |
4,049,195 |
| TOTAL |
279,755 |
3,006,381,300 |
Return to list of variables
|
Back
Email Updates
